Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology and the Vasculitis Foundation have released new guidelines for Kawasaki ...

Pediatric patients with Kawasaki disease (KD), especially those resistant to intravenous immunoglobulin (IVIG), appear to benefit from early adjunctive corticosteroids, according to a small ...

A new tool under development by UB researchers could one day help clinicians better predict resistance to immunoglobulin therapy among children with Kawasaki disease in the United States. The new tool ...

Combining intravenous methylprednisolone pulse and intravenous immunoglobulin to treat patients with Kawasaki disease appears safe and effective, according to data published online this week. Shohei ...

SAN DIEGO, CA—Adding infliximab to standard intravenous immunoglobulin (IVIG) to reduce inflammation in acute Kawasaki disease (KD) is safe in children, even those younger than 1 year of age, ...

Kawasaki disease is now considered the leading cause of acquired heart disease among children in developed countries such as the United States and Japan. In most cases, up to 80 percent, treatment ...

BUFFALO, N.Y. – A new tool under development by University at Buffalo researchers could one day help clinicians better predict resistance to immunoglobulin therapy among children with Kawasaki disease ...

A new tool could one day help clinicians better predict resistance to immunoglobulin therapy among children with Kawasaki disease in the United States. Compared to the Kobayashi score -- the most ...